Total Payments
$512,903
2024 Payments
$3,124
Companies
71
Transactions
1,744
Medicare Patients
3,934
Medicare Billing
$419,790
Payment Breakdown by Category
Other$391,293 (76.3%)
Consulting$57,590 (11.2%)
Travel$32,810 (6.4%)
Food & Beverage$26,272 (5.1%)
Research$4,590 (0.9%)
Education$349.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $391,293 | 189 | 76.3% |
| Consulting Fee | $57,590 | 24 | 11.2% |
| Travel and Lodging | $32,810 | 78 | 6.4% |
| Food and Beverage | $26,272 | 1,443 | 5.1% |
| Unspecified | $4,590 | 3 | 0.9% |
| Education | $349.20 | 7 | 0.1% |
Payments by Type
General
$508,314
1,741 transactions
Research
$4,590
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $162,686 | 169 | $0 (2023) |
| Biogen, Inc. | $81,007 | 127 | $0 (2024) |
| Genentech USA, Inc. | $72,645 | 110 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $70,736 | 162 | $0 (2024) |
| EMD Serono, Inc. | $47,504 | 151 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $23,124 | 48 | $0 (2019) |
| Celgene Corporation | $11,313 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $8,765 | 106 | $0 (2024) |
| Acorda Therapeutics, Inc | $8,114 | 35 | $0 (2024) |
| Allergan, Inc. | $5,309 | 44 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,124 | 224 | ABBVIE INC. ($498.88) |
| 2023 | $4,343 | 217 | Eli Lilly and Company ($905.00) |
| 2022 | $9,750 | 173 | Biogen, Inc. ($5,229) |
| 2021 | $18,320 | 73 | Biogen, Inc. ($4,932) |
| 2020 | $53,364 | 108 | Biogen, Inc. ($16,332) |
| 2019 | $124,834 | 330 | GENZYME CORPORATION ($54,057) |
| 2018 | $145,948 | 288 | GENZYME CORPORATION ($54,942) |
| 2017 | $153,221 | 331 | GENZYME CORPORATION ($50,910) |
All Payment Transactions
1,744 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Immunology | ||||||
| 12/13/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: PAIN | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: PAIN | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neurology | ||||||
| 12/04/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Neuroscience | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.13 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $3,685 | 2 |
| A STUDY OF DONANEMAB (LY3002813) IN PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 2) | Eli Lilly and Company | $905.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 921 | 11,742 | $561,427 | $98,684 |
| 2022 | 14 | 894 | 9,632 | $519,884 | $91,546 |
| 2021 | 17 | 1,031 | 18,010 | $588,927 | $115,392 |
| 2020 | 13 | 1,088 | 13,621 | $482,255 | $114,167 |
Total Patients
3,934
Total Services
53,005
Medicare Billing
$419,790
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 362 | 613 | $224,971 | $52,566 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 186 | $47,988 | $10,886 | 22.7% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 64 | 66 | $95,700 | $8,726 | 9.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 99 | 99 | $31,284 | $7,719 | 24.7% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 74 | 75 | $64,350 | $6,608 | 10.3% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 25 | 26 | $35,204 | $3,926 | 11.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 23 | $10,316 | $1,957 | 19.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 45 | $20,386 | $1,822 | 8.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 14 | 14 | $11,690 | $1,281 | 11.0% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 70 | 10,550 | $10,550 | $1,155 | 10.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $4,851 | $1,143 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 21 | $3,318 | $698.13 | 21.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 13 | $819.00 | $197.98 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 377 | 608 | $223,136 | $51,179 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 162 | $41,796 | $8,956 | 21.4% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 56 | 57 | $82,650 | $8,114 | 9.8% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 70 | 72 | $61,776 | $6,564 | 10.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 87 | 87 | $27,492 | $6,275 | 22.8% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2022 | 19 | 19 | $18,772 | $2,135 | 11.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 19 | 20 | $7,340 | $1,804 | 24.6% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2022 | 11 | 11 | $14,894 | $1,486 | 10.0% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 13 | 13 | $10,855 | $1,138 | 10.5% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2022 | 14 | 15 | $14,820 | $1,103 | 7.4% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2022 | 57 | 8,500 | $8,500 | $924.03 | 10.9% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 15 | 33 | $3,267 | $804.42 | 24.6% |
About Dr. Lee Stein, MD
Dr. Lee Stein, MD is a Neurology healthcare provider based in Cordova, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558392233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Stein, MD has received a total of $512,903 in payments from pharmaceutical and medical device companies, with $3,124 received in 2024. These payments were reported across 1,744 transactions from 71 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($391,293).
As a Medicare-enrolled provider, Stein has provided services to 3,934 Medicare beneficiaries, totaling 53,005 services with total Medicare billing of $419,790. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cordova, TN
- Active Since 07/05/2006
- Last Updated 02/03/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1558392233
Products in Payments
- AUBAGIO (Drug) $115,980
- OCREVUS (Biological) $65,681
- COPAXONE (Drug) $57,230
- LEMTRADA (Drug) $46,657
- TECFIDERA (Drug) $39,434
- Rebif (Biological) $33,396
- TYSABRI (Biological) $29,467
- ACTHAR (Biological) $23,171
- ZEPOSIA (Drug) $11,746
- AJOVY (Biological) $11,416
- Mavenclad (Biological) $11,118
- AMPYRA (Drug) $7,786
- Non-Covered Product (Drug) $6,772
- VUMERITY (Drug) $5,754
- UBRELVY (Drug) $5,355
- Betaseron (Drug) $5,283
- MAYZENT (Drug) $5,087
- ZINBRYTA (Biological) $2,535
- Mavenclad (Drug) $2,395
- AJOVY (Drug) $1,841
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cordova
Dr. Oleksandra Dryn, M.d, M.D
Neurology — Payments: $109,164
Neurology $109,164
Dr. Thomas Arnold, M.d, M.D
Neurology — Payments: $47,871
Neurology $47,871
Kendrick Henderson, Md, MD
Neurology — Payments: $31,757
Neurology $31,757
Dr. David Pritchard, M.d, M.D
Neurology — Payments: $27,827
Neurology $27,827
Bola Adamolekun, Md, MD
Neurology — Payments: $27,159
Neurology $27,159
Barbara Obrien, M.d, M.D
Neurology — Payments: $22,899
Neurology $22,899